Literature DB >> 12852456

Analysis and pharmacokinetics of bulaquine and its major metabolite primaquine in rabbits using an LC-UV method--a pilot study.

Jawahar Lal1, Nitin Mehrotra, Ram Chandra Gupta.   

Abstract

A precise and reproducible HPLC assay has been developed and validated for simultaneous determination of bulaquine (BQ) and its metabolite primaquine (PQ) in rabbit plasma. The method, applicable to 0.5 ml plasma, involves double extraction of samples with n-hexane: isopropanol (98:2, v/v) containing dimethyl octylamine (DMOA) (0.1%, v/ v). Separations were accomplished by reversed-phase liquid chromatography using a Spheri-5 cyano column with a low pressure gradient with mobile phase consisting of ammonium acetate buffer (50 mM, pH 6.0) and acetonitrile with DMOA. The method was sensitive with a limit of quantitation of 20 ng ml(-1) in rabbit plasma for both BQ and PQ and the recoveries were > 85 and > 45%, respectively. Excellent linear relationships (r > 0.99) were obtained between the measured and added concentration ratios of the plasma concentrations over a range of 20-1000 ng ml(-1) for both the analytes. Precision and accuracy were acceptable as indicated by relative standard deviations from 1.8 to 15.1%, bias values ranging from -14.2 to 15.7%. Moreover, BQ was stable in rabbit plasma for 15 days of storage at -60 degrees C and after being subjected to three freeze-thaw cycles. The method was applied to determine the levels and pharmacokinetics of BQ in rabbits following a single 2.5 mg kg(-1) oral and intravenous dose. The BQ levels declined and the PQ levels increased with time. The PQ/BQ ratio after oral dose at 1 and 1.5 h were higher than that after intravenous dose. In the pilot preclinical pharmacokinetic study after a single 2.5 mg kg(-1) oral dose, BQ levels were determined up to 6 h (post-prandial) and 8 h (fasting). The plasma concentration versus time data were best fitted to a two-compartment open model with first-order absorption and elimination processes without lag time. The AUC(0-infinity) and the elimination t1/2 in fasted rabbit was higher than that in post-prandial rabbit indicating the effect of food on BQ pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12852456     DOI: 10.1016/s0731-7085(03)00033-5

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Increased bioavailability of primaquine using poly(ethylene oxide) matrix extended-release tablets administered to beagle dogs.

Authors:  C D Bertol; P R Oliveira; G Kuminek; G S Rauber; H K Stulzer; M A S Silva
Journal:  Ann Trop Med Parasitol       Date:  2011-10

2.  Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry.

Authors:  Warunee Hanpithakpong; Nicholas P J Day; Nicholas J White; Joel Tarning
Journal:  Malar J       Date:  2022-06-03       Impact factor: 3.469

3.  Electrospray ionization-ion trap mass spectrometry study of PQAAPro and PQProAA mimetic derivatives of the antimalarial primaquine.

Authors:  Nuno Vale; Joana Matos; Rui Moreira; Paula Gomes
Journal:  J Am Soc Mass Spectrom       Date:  2008-07-01       Impact factor: 3.109

4.  A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria [ISCRTN50134587].

Authors:  N J Gogtay; K D Kamtekar; S S Dalvi; S S Mehta; A R Chogle; U Aigal; N A Kshirsagar
Journal:  BMC Infect Dis       Date:  2006-02-01       Impact factor: 3.090

5.  Pharmacokinetic study and bioavailability of a novel synthetic trioxane antimalarial compound 97/63 in rats.

Authors:  Hari Narayan Kushwaha; Neel Kamal Mohan; Ashok Kumar Sharma; Shio Kumar Singh
Journal:  Malar Res Treat       Date:  2014-09-11

6.  Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry.

Authors:  Bharathi Avula; Babu L Tekwani; Narayan D Chaurasiya; Pius Fasinu; N P Dhammika Nanayakkara; H M T Bhandara Herath; Yan-Hong Wang; Ji-Yeong Bae; Shabana I Khan; Mahmoud A Elsohly; James D McChesney; Peter A Zimmerman; Ikhlas A Khan; Larry A Walker
Journal:  Malar J       Date:  2018-08-13       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.